Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series

Falcone Francesca; Normanno Nicola; Losito Nunzia S.; Scognamiglio Giosue; Abate Riziero Esposito; Chicchinelli Nicoletta; Casella Gennaro; Laurelli Giuseppe; Scaffa Cono; Greggi Stefano

首页> 外文期刊>European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal >Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series

【24h】

Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series

机译：主动分子风险分类器在保守治疗患者的子宫内膜癌中的应用：机构系列的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To test the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) and determine the frequency of specific/prognostic molecular alterations within a cohort of endometrial cancer (EC) women conservatively treated by combined hysteroscopic resection and progestin therapy.

机译：目的：测试子宫内膜癌（承诺）的主动分子风险分类器，并确定由宫腔镜切除和孕激素治疗保守治疗子宫内膜癌（EC）女性的特异性/预后分子变化的频率。

著录项

来源
《European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal》 |2019年第2019期|共6页
作者
Falcone Francesca; Normanno Nicola; Losito Nunzia S.; Scognamiglio Giosue; Abate Riziero Esposito; Chicchinelli Nicoletta; Casella Gennaro; Laurelli Giuseppe; Scaffa Cono; Greggi Stefano;
展开▼
作者单位

Fdn G Pascale IRCSS Ist Nazl Tumori Dept Gynecol Oncol Surg Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Cell Biol &

Biotherapy Unit Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Pathol Unit Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Pathol Unit Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Cell Biol &

Biotherapy Unit Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Cell Biol &

Biotherapy Unit Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Dept Gynecol Oncol Surg Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Dept Gynecol Oncol Surg Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Dept Gynecol Oncol Surg Naples Italy;

Fdn G Pascale IRCSS Ist Nazl Tumori Dept Gynecol Oncol Surg Naples Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词
Endometrial neoplasm; Fertility preservation; Molecular typing; Hysteroscopy;

机译：子宫内膜肿瘤;生育保存;分子键入;宫腔镜检查;

相似文献

外文文献
中文文献
专利

1. Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series [J] . Falcone Francesca, Normanno Nicola, Losito Nunzia S., European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal . 2019,第期

机译：主动分子风险分类器在保守治疗患者的子宫内膜癌中的应用：机构系列的结果
2. Long-term Cancer Control Outcomes in Patients with Clinically High-risk Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Results from a Multi-institutional Study of 1100 Patients [J] . Abdollah Firas, Sood Akshay, Sammon Jesse D., European urology . 2015,第3期

机译：机器人辅助根治性前列腺切除术治疗的临床高危前列腺癌患者的长期癌症控制结果：来自1100例患者的多机构研究结果
3. Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review. [J] . Chao AS, Chao A, Wang CJ, Taiwanese journal of obstetrics and gynecology . 2011,第1期

机译：子宫内膜癌保守治疗后妊娠的产科预后：病例系列和文献复习。
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. National and Institutional Outcomes Data in Head and Neck Cancers, and Functional and Patient Reported Outcomes in Patients with Oropharyngeal Cancers. [D] . Kansal, Ankit. 2017

机译：头颈癌的国家和机构结局数据，以及口咽癌患者的功能和患者报告结局。
6. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups [O] . Eirwen M. Miller, Nicole E. Patterson, Gregory M. Gressel, 2020

机译：自定义设计的下一代DNA测序基因面板的实用性根据癌症基因组Atlas亚组分子分类子宫内膜癌
7. 97 Practicing knowledge translation: building awareness and assessing barriers and facilitators to provincial implementation of the proactive molecular risk classifier for endometrial cancer (ProMisE) [O] . N Prestley, M Woo, A Talhouk, 2020

机译：97练习知识译文：建立意识和评估局部实施子宫内膜癌主动分子风险分类器的障碍和促进者（承诺）

Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series

摘要

著录项

相似文献

相关主题

期刊订阅